Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dulcolax in post-operative OB/GYN patients
NCT01011426Phase 2Completed
- Sponsor
- Cooper University Health Care
- Start
- Apr 2009
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of bisacodyl in postoperative nausea and vomiting (PONV), abdominal pain and postoperative ileus (POI), sponsored by Cooper University Health Care. Primary endpoint: Incidence of nausea and vomiting. Started Apr 2009; status: completed.
02
Drugs
bisacodyl
03
Conditions
postoperative nausea and vomiting (PONV)abdominal painpostoperative ileus (POI)
Beyond the preview
Go deeper on NCT01011426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01011426.